Seguir
Arturo Araujo
Arturo Araujo
University of Roehampton, London
Dirección de correo verificada de cancerevo.org - Página principal
Título
Citado por
Citado por
Año
An integrated computational model of the bone microenvironment in bone-metastatic prostate cancer
A Araujo, LM Cook, CC Lynch, D Basanta
Cancer research 74 (9), 2391-2401, 2014
972014
Integrating new discoveries into the "vicious cycle" paradigm of prostate to bone metastases
LCC Cook LM, Shay G, Araujo A
Cancer and Metastasis Reviews 33 (2-3), 511-525, 2014
932014
Predictive computational modeling to define effective treatment strategies for bone metastatic prostate cancer
LM Cook, A Araujo, JM Pow-Sang, MM Budzevich, D Basanta, CC Lynch
Scientific reports 6 (1), 29384, 2016
532016
Cancer heterogeneity: converting a limitation into a source of biologic information
A Rübben, A Araujo
Journal of Translational Medicine 15, 1-10, 2017
402017
Improving treatment strategies for patients with metastatic castrate resistant prostate cancer through personalized computational modeling
J Gallaher, LM Cook, S Gupta, A Araujo, J Dhillon, JY Park, JG Scott, ...
Clinical & experimental metastasis 31, 991-999, 2014
272014
The role of chromosome missegregation in cancer development: a theoretical approach using agent-based modelling
A Araujo, B Baum, P Bentley
PloS one 8 (8), e72206, 2013
172013
Size Matters: Metastatic cluster size and stromal recruitment in the establishment of successful prostate cancer to bone metastases
A Araujo, LM Cook, CC Lynch, D Basanta
Bulletin of mathematical biology 80, 1046-1058, 2018
152018
Fractionated follow-up chemotherapy delays the onset of resistance in bone metastatic prostate cancer
PI Warman, A Kaznatcheev, A Araujo, CC Lynch, D Basanta
Games 9 (2), 19, 2018
112018
Toxicity Management in CAR T cell therapy for B-ALL: Mathematical modelling as a new avenue for improvement
S Hanson, DR Grimes, JP Taylor-King, B Bauer, PI Warman, ...
bioRxiv, 049908, 2016
92016
Quantification and optimization of standard-of-care therapy to delay the emergence of resistant bone metastatic prostate cancer
A Araujo, LM Cook, JS Frieling, W Tan, JA Copland, M Kohli, S Gupta, ...
Cancers 13 (4), 677, 2021
72021
Correlative monitoring of immune activation and tissue damage in malignant melanoma—an algorithm for identification of tolerance breakage during immune checkpoint inhibitor …
RU Wahl, M Leijs, A Araujo, A Rübben
International Journal of Molecular Sciences 21 (6), 2020, 2020
62020
Modelling the Role of Aneuploidy in Tumour Evolution.
A Araujo, PJ Bentley, B Baum
ALIFE, 488-495, 2010
52010
Testing three hypotheses of the contribution of geometry and migration dynamics to intestine crypt evolution
A Araujo, A Rübben, PJ Bentley, D Basanta
Artificial Life Conference Proceedings, 420-427, 2018
42018
A distinct four-value blood signature of pyrexia under combination therapy of malignant melanoma with dabrafenib and trametinib evidenced by an algorithm-defined pyrexia score
H Schaefer, A Rübben, A Esser, A Araujo, OD Persa, M Leijs
Plos one 17 (8), e0273478, 2022
32022
Investigating the Origins of Cancer in the Intestinal Crypt with a Gene Network Agent Based Hybrid Model
A Araujo, H Zhang, A Rübben, PJ Bentley
Artificial Life Conference Proceedings, 195-202, 2019
32019
IMO-HIP 2015 Report: An Evolutionary Game Theory Approach to evolutionary-enlightened application of chemotherapy in bone metastatic prostate cancer
P Warman, A Araujo, C Lynch, D Basanta
Biorxiv, 030262, 2015
12015
Defining the temporal effects of TGFβ inhibition on the cellular heterogeneity of the bone metastatic prostate cancer microenvironment
LM Cook, A Araujo, D Basanta, CC Lynch
Cancer Research 75 (15_Supplement), 3751-3751, 2015
12015
Optimizing personalized treatment sequences in metastatic castration resistant prostate cancer using tumor-biomarker based computational modeling.
S Gupta, J Gallaher, C Lynch, L Cook, A Araujo, J Scott, J Dhillon, ...
Journal of Clinical Oncology 33 (15_suppl), e16014-e16014, 2015
12015
Modelling Chromosome Missegregation in Tumour Evolution
A Araujo
UCL (University College London), 2013
12013
A distinct four-value blood signature of pyrexia under combination therapy of malignant melanoma with BRAF/MEK-inhibitors evidenced by an algorithm-defined pyrexia score
H Schaefer, A Rübben, A Esser, A Araujo, OD Persa, M Leijs
medRxiv, 2022.03. 29.22272913, 2022
2022
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20